Living With Coccidioidomycosis
Most people diagnosed with coccidioidomycosis will not require therapy and the disease will go away on its own. Some people have symptoms that persist for months after resolution of the disease, while others may require prolonged treatment.
What To Expect
People affected by acute coccidioidomycosis that do not require therapy should follow up regularly with their healthcare providers for the first year after diagnosis, as they are at a higher risk for developing chronic or disseminated infection during this time. Many diagnosed individuals will be referred to a pulmonary or infectious disease specialist, although this is less likely to happen in regions where the primary care provider is familiar with the disease. Although all symptoms eventually go away in the majority of diagnosed individuals, many experience profound fatigue lasting several months. Individuals diagnosed with coccidioidomycosis can participate in regular work, exercise and diet routines if symptoms permit. In such cases, reconditioning physical therapy may be beneficial.
Follow-up examinations with your healthcare provider, as well as follow-up blood testing and imaging, such as chest X-rays or CT scans, are recommended during the first year after infection. People diagnosed with coccidioidomycosis without signs of chronic or widespread disease are not at risk for getting coccidioidomycosis again unless they develop depressed immune systems.
Disease information and resources regarding specialty centers and support may be found through the Valley Fever Center for Excellence.
The Lung Association recommends patients and caregivers join our Living with Lung Disease Support Community to connect with others facing this disease. You can also call the Lung Association's Lung Helpline at 1-800-LUNGUSA to talk to a trained respiratory professional who can help answer your questions and connect you with additional support.
Last updated April 4, 2018.
Sign up for the latest lung health news delivered right to your inbox.
Join more than 500,000 people who receive research updates, inspiring stories, health information and more.